Lisdexamfetamine, commonly known as Vyvanse, is a scheduled drug approved in Canada for addressing Attention-Deficit/Hyperactivity Disorder (ADHD) in individuals and adults . The medication functions as a https://sandozlisdexamfetaminein066536.gynoblog.com/42180505/vyvanse-in-this-country-a-comprehensive-guide